FIELD: genetic engineering, medicine, oncology.
SUBSTANCE: invention relates to applying nucleic acid molecules encoding polypeptides and dimmers of polypeptides - lectins from white mistletoe (Viscum album) provides detecting the presence of corresponding genes in body and these polypeptides and their dimmers can be used as components of agents eliciting immunostimulating and cytotoxic activity. Invention can be used for therapeutic aims, in particular, in therapy of tumor processes.
EFFECT: valuable medicinal properties of lectin.
20 cl, 26 dwg, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT MISTLETOE LECTIN AND USE THEREOF AS ADJUVANT | 2012 |
|
RU2664458C2 |
| METHOD FOR OBTAINING A VEGETABLE ML1 LECTURE FROM A MISSILE WHITE AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS (VARIANTS) | 2016 |
|
RU2644332C1 |
| PHARMACUTICAL, CONTAINING RECOMBINANT MISTLETOE LECTIN, FOR TREATMENT OF MELANOTIC CANCER | 2012 |
|
RU2639445C2 |
| HUMAN RECOMBINANT MANNAN-BINDING LECTIN | 2000 |
|
RU2292217C2 |
| DISEASE-RELATED PROTEIN | 2002 |
|
RU2384586C2 |
| FUSED POLYPEPTIDE OR ITS SALT, EXPRESSING VECTOR AND PHARMACEUTICAL COMPOSITION DESIGNATED FOR TREATMENT OF IGE-MEDIATED DISEASES | 1997 |
|
RU2209211C2 |
| NEW FUCOSYLTRANSFERASES AND APPLICATIONS THEREOF | 2011 |
|
RU2628307C2 |
| POLYPEPTIDES OF DIRECTED ACTION | 2006 |
|
RU2393874C2 |
| CHEMERIC IMPROVED RECOMBINANT FACTOR VIII | 2015 |
|
RU2647769C2 |
| DNA FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT | 1994 |
|
RU2218400C2 |
